Pfizer Inc. (FRA:PFE)
20.29
-0.02 (-0.07%)
Aug 1, 2025, 7:08 PM CET
Pfizer Revenue
Pfizer had revenue of $13.72B USD in the quarter ending March 30, 2025, a decrease of -7.82%. This brings the company's revenue in the last twelve months to $62.46B, up 11.65% year-over-year. In the year 2024, Pfizer had annual revenue of $63.63B with 6.84% growth.
Revenue (ttm)
$62.46B
Revenue Growth
+11.65%
P/S Ratio
2.01
Revenue / Employee
$771.16K
Employees
81,000
Market Cap
115.75B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63.63B | 4.07B | 6.84% |
Dec 31, 2023 | 59.55B | -41.62B | -41.14% |
Dec 31, 2022 | 101.18B | 19.89B | 24.46% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.17B |
Pfizer News
- 1 day ago - Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says - Forbes
- 1 day ago - Trump pressures 17 pharma CEOs to cut US drug prices - Reuters
- 1 day ago - Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days - CNBC
- 2 days ago - Buy 9 Barron's Better Bets (Than T-Bills) From 16 'Safer' July DiviDogs - Seeking Alpha
- 3 days ago - Drug Prices To Get 'More Expensive' Under Trump's EU Trade Deal As Pharma Faces Billions In Added Costs: Report - Benzinga
- 3 days ago - BenchSci Expands Board of Directors with Appointment of Dr. Mikael Dolsten - Financial Post
- 4 days ago - Celcuity Stock Skyrockets On Breakthrough Trial Data For Heavily Pretreated Breast Cancer - Benzinga
- 5 days ago - Notable healthcare headlines for the week: Pfizer, UnitedHealth, Sarepta and Thermo Fisher in focus - Seeking Alpha